Assignee
RAZE THERAPEUTICS INC
US·8 granted patents·2 pending applications·9 citations·filing 2016–2023
Top patents by PatentIndex Score
10 records- 0187US11014882B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·3 cites·12 claims
- 0286US11535593B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·1 cites·18 claims
- 0386US10954220B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted Mar 23, 2021·3 cites·16 claims
- 0479US11370792B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2016·Granted Jun 28, 2022·2 cites·20 claims
- 0576US2023312536A13-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0675US12264132B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·16 claims
- 0768US11634412B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Granted Apr 25, 2023·0 cites·19 claims
- 0864US12187728B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·0 cites·16 claims
- 0964US2023061841A1Shmt inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1063US11091451B2SHMT inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted Aug 17, 2021·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →